These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 29194673

  • 21. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
    Persa OD, Knuever J, Mauch C, Schlaak M.
    J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
    [Abstract] [Full Text] [Related]

  • 22. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Bello DM, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D.
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
    [Abstract] [Full Text] [Related]

  • 23. Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma.
    Santos FMD, Silva FCD, Pedron J, Furian RD, Fortes C, Bonamigo RR.
    An Bras Dermatol; 2019 Dec; 94(1):47-51. PubMed ID: 30726463
    [Abstract] [Full Text] [Related]

  • 24. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY, Tufaro AP, Manson PN.
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [Abstract] [Full Text] [Related]

  • 25. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [Abstract] [Full Text] [Related]

  • 26. Stratifying SLN incidence in intermediate thickness melanoma patients.
    Chang JM, Kosiorek HE, Dueck AC, Leong SPL, Vetto JT, White RL, Avisar E, Sondak VK, Messina JL, Zager JS, Garberoglio C, Kashani-Sabet M, Pockaj BA.
    Am J Surg; 2018 Apr; 215(4):699-706. PubMed ID: 29502857
    [Abstract] [Full Text] [Related]

  • 27. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
    Fujisawa Y, Otsuka F, Japanese Melanoma Study Group.
    Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
    Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.
    Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
    [Abstract] [Full Text] [Related]

  • 30. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
    Egger ME, Huber KM, Dunki-Jacobs EM, Quillo AR, Scoggins CR, Martin RC, Stromberg AJ, McMasters KM, Callender GG.
    J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
    [Abstract] [Full Text] [Related]

  • 31. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ, Song Y, Sharon CE, Yang YX, Elder DE, Zhang PJ, Xu X, Roses RE, Kelz RR, Fraker DL, Karakousis GC.
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [Abstract] [Full Text] [Related]

  • 32. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
    Paek SC, Griffith KA, Johnson TM, Sondak VK, Wong SL, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.
    Cancer; 2007 Jan 01; 109(1):100-8. PubMed ID: 17146784
    [Abstract] [Full Text] [Related]

  • 33. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
    Boada A, Tejera-Vaquerizo A, Ribero S, Puig S, Moreno-Ramírez D, Quaglino P, Osella-Abate S, Cassoni P, Malvehy J, Carrera C, Pigem R, Barreiro-Capurro A, Requena C, Traves V, Manrique-Silva E, Fernández-Orland A, Ferrandiz L, García-Senosiain O, Fernández-Figueras MT, Ferrándiz C, Nagore E, SENTIMEL study group.
    Eur J Surg Oncol; 2020 Feb 01; 46(2):263-271. PubMed ID: 31594672
    [Abstract] [Full Text] [Related]

  • 34. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.
    Ann Surg; 2012 Jan 01; 255(1):128-33. PubMed ID: 21975320
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
    Homolak D, Šitum M, Čupić H.
    Acta Dermatovenerol Croat; 2015 Jan 01; 23(2):122-9. PubMed ID: 26228823
    [Abstract] [Full Text] [Related]

  • 39. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
    Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH.
    Melanoma Res; 2010 Aug 01; 20(4):330-7. PubMed ID: 20526218
    [Abstract] [Full Text] [Related]

  • 40. Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate.
    Knackstedt R, Couto RA, Ko J, Cakmakoglu C, Wu D, Gastman B.
    Ann Surg Oncol; 2019 Oct 01; 26(11):3550-3560. PubMed ID: 31313036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.